Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 630–631 | Cite as

Current Practice and Future Directions for Metaplastic Breast Cancer

  • Waqar HaqueEmail author
  • Bin S. Teh
ASO Author Reflections



Waqar Haque and Bin S. Teh have no conflict of interest to disclose.


  1. 1.
    Tseng WH, Martinez SR. Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol. 2011;18:94–103.CrossRefGoogle Scholar
  2. 2.
    Luini A, Aguilar M, Gatti G, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2007;101:349–353.CrossRefGoogle Scholar
  3. 3.
    Haque W, Verma V, Naik N, Butler EB, Teh BS. Metaplastic breast cancer: practice patterns, outcomes, and the role of radiotherapy. Ann Surg Oncol. 2018;25:928–36.CrossRefGoogle Scholar
  4. 4.
    Joneja U, Vranic S, Swensen J, et al. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1. J Clin Path. 2017;70:255–59.CrossRefGoogle Scholar
  5. 5.
    Adams S. Dramatic response of metaplastic breast cancer to chemo-immunotherapy. NPJ Breast Cancer 2017;3:8.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyHouston Methodist HospitalHoustonUSA

Personalised recommendations